These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11873057)

  • 1. Delayed postoperative rhabdomyolysis in a patient subsequently diagnosed as malignant hyperthermia susceptible.
    McKenney KA; Holman SJ
    Anesthesiology; 2002 Mar; 96(3):764-5. PubMed ID: 11873057
    [No Abstract]   [Full Text] [Related]  

  • 2. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.
    Capacchione JF; Sambuughin N; Bina S; Mulligan LP; Lawson TD; Muldoon SM
    Anesthesiology; 2010 Jan; 112(1):239-44. PubMed ID: 20010423
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.
    Riazi S; Kraeva N; Hopkins PM
    Anesthesiology; 2018 Jan; 128(1):168-180. PubMed ID: 28902675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fever-induced recurrent rhabdomyolysis due to a novel mutation in the ryanodine receptor type 1 gene.
    Molenaar JP; Voermans NC; van Hoeve BJ; Kamsteeg EJ; Kluijtmans LA; Kusters B; Jungbluth HJ; van Engelen BG
    Intern Med J; 2014 Aug; 44(8):819-20. PubMed ID: 25081049
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
    Kraeva N; Sapa A; Dowling JJ; Riazi S
    Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis and acute renal failure as a complication of urethral surgery.
    Leventhal I; Schiff H; Wulfsohn M
    Urology; 1985 Jul; 26(1):59-61. PubMed ID: 4012981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathic changes in malignant hyperthermia-susceptible patients.
    Rosenberg H
    Can J Anaesth; 2013 Oct; 60(10):955-9. PubMed ID: 23897489
    [No Abstract]   [Full Text] [Related]  

  • 8. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
    Voermans NC; Snoeck M; Jungbluth H
    Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat production during anesthetic-induced malignant hyperthermia.
    Nelson TE
    Biosci Rep; 2001 Apr; 21(2):169-79. PubMed ID: 11725865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

  • 11. Could this be malignant hyperthermia?
    Choiniere A
    Anesth Analg; 2008 Apr; 106(4):1327-8; author reply 1328-9. PubMed ID: 18349216
    [No Abstract]   [Full Text] [Related]  

  • 12. A fulminant malignant hyperthermia episode in a patient with ryanodine receptor gene mutation p.Tyr522Ser.
    Girard T; Suhner M; Levano S; Singer M; Zollinger A; Hofer CK
    Anesth Analg; 2008 Dec; 107(6):1953-5. PubMed ID: 19020143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia.
    Hopkins PM; Gupta PK; Bilmen JG
    Handb Clin Neurol; 2018; 157():645-661. PubMed ID: 30459030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees.
    Davis M; Brown R; Dickson A; Horton H; James D; Laing N; Marston R; Norgate M; Perlman D; Pollock N; Stowell K
    Br J Anaesth; 2002 Apr; 88(4):508-15. PubMed ID: 12066726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of malignant hyperthermia.
    Brandom BW
    ScientificWorldJournal; 2006 Dec; 6():1722-30. PubMed ID: 17195870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia and its implications in general dentistry.
    Reifenstahl EF; Rowshan HH
    Gen Dent; 2009; 57(3):242-6; quiz 247-8. PubMed ID: 19819813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive postoperative rhabdomyolysis after uneventful surgery: a case report of subclinical malignant hyperthermia.
    Harwood TN; Nelson TE
    Anesthesiology; 1998 Jan; 88(1):265-8. PubMed ID: 9447881
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test.
    Roux-Buisson N; Monnier N; Sagui E; Abriat A; Brosset C; Bendahan D; Kozak-Ribbens G; Gazzola S; Quesada JL; Foutrier-Morello C; Rendu J; Figarella-Branger D; Cozonne P; Aubert M; Bourdon L; Lunardi J; Fauré J
    Br J Anaesth; 2016 Apr; 116(4):566-8. PubMed ID: 26994242
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal inherited rhabdomyolysis and malignant hyperthermia.
    Denborough MA; McLean A; Morgan G; Hopkinson KC
    Lancet; 1994 Jan; 343(8891):236-7. PubMed ID: 7904690
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.